EDITORIAL
Published on 06 Sep 2019
Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy
doi 10.3389/fimmu.2019.02083
- 2,375 views
- 8 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Combinatorial Approaches to Enhance Anti-Tumor Immunity: focus on Immune checkpoint blockade therapy
Combinatorial Approaches to Enhance Anti-Tumor Immunity: focus on Immune checkpoint blockade therapy
76k
Total downloads
270k
Total views and downloads
Articles
REVIEW
Published on 23 Jul 2019
Targeting Myeloid Cells in Combination Treatments for Glioma and Other Tumors
doi 10.3389/fimmu.2019.01715
- 7,423 views
- 43 citations
REVIEW
Published on 05 Apr 2019
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
doi 10.3389/fimmu.2019.00698
- 18,701 views
- 77 citations
ORIGINAL RESEARCH
Published on 22 Mar 2019
Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer
doi 10.3389/fimmu.2019.00454
- 5,722 views
- 55 citations
REVIEW
Published on 19 Mar 2019
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
doi 10.3389/fimmu.2019.00453
- 24,663 views
- 201 citations
MINI REVIEW
Published on 14 Mar 2019
Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
doi 10.3389/fimmu.2019.00467
- 20,496 views
- 141 citations
REVIEW
Published on 15 Feb 2019
Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment
doi 10.3389/fimmu.2019.00193
- 10,555 views
- 133 citations
ORIGINAL RESEARCH
Published on 13 Feb 2019
Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1
doi 10.3389/fimmu.2019.00211
- 5,207 views
- 45 citations
ORIGINAL RESEARCH
Published on 08 Feb 2019
PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185erbB2/neu Tumor Immunotherapy
doi 10.3389/fimmu.2019.00174
- 6,813 views
- 68 citations
REVIEW
Published on 31 Jan 2019
Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment
doi 10.3389/fimmu.2018.03154
- 10,499 views
- 106 citations
REVIEW
Published on 14 Jan 2019
Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy
doi 10.3389/fimmu.2018.03077
- 9,695 views
- 50 citations
REVIEW
Published on 14 Jan 2019
Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
doi 10.3389/fimmu.2018.03107
- 9,375 views
- 86 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
T Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore